Market Research Report
January 8, 2020

Medical Simulation Market Will Exceed $3.6 Bn By 2027

Medical Simulation Market (By Product & Service: Anatomical Models, Web-based Simulation, Simulation Training Services; By Technology: Low-fidelity Simulators, Medium-fidelity Simulators, High-fidelity Simulators; By End-User: Academic Institutions & Research Centers, Hospitals & Clinics) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2027

The medical simulation market size is expected to be worth around Us$ 3.6 billion By 2027, With projected to the growth of 12.1% CAGR over the forecast time frame 2019-2027.

Download Free Sample Report Pages@ https://www.acumenresearchandconsulting.com/request-sample/1648

North America held the maximum share of the global medical simulation market in 2018 and is anticipated to hold its share during the forecast period. This can be attributed to more adoption of simulation technology by medical institutes and universities, easy access to technology due to the local presence of market players, and strong distribution channels across the region. Furthermore, the growing number of trainee healthcare professionals and well-established healthcare infrastructure are some of the other factors for the dominance of the region. Europe held the second-largest share of the market. However, Asia Pacific is anticipated to propel the market at the fastest rate during the forecast period. This can be attributed to a large number of medical institutes and universities, growing awareness about simulation learning, government funding, and increasing focus on patient safety. For instance, in October 2018, Bangalore Medical College & Research Institute (BMCRI) received Rs. 22 Crore for simulation lab from the state government. Furthermore, investment by global healthcare simulation players in the region due to the presence of unmet needs and increasing healthcare expenditure are key factors responsible for the growth of the market in the region during the forecast period.

Based on the product & service, the market has been segmented into anatomical models, web-based simulation, and simulation training services. The anatomical model accounted for the largest share of the market in 2018. This can be attributed to benefits associated with the anatomical model such as understanding key concepts through practical information. Furthermore, an increase in focus on patient safety helps to enhance the demand for anatomical models for academic purposes. However, the web-based simulation segment is anticipated to observe the fastest growth during the forecast period. Web-based simulation combines electronic multimedia options with a central video or virtual world to create interactive learning activities. An increase in the usage of internet services is anticipated to observe significant growth during the forecast period.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/medical-simulation-market

Based on the technology, the medical simulation market is divided into low-fidelity simulators, medium-fidelity simulators, and high fidelity simulators. Low-fidelity simulators accounted for the largest share in 2018. However, the high fidelity simulators segment is expected to observe the fastest growth during the forecast period.

Based on the end-user, the market has been divided into academic & research institutes and hospitals. The academic & research institute segment held the maximum share in 2018 and is anticipated to observe the significant growth during the forecast period. This can be attributed to the increase in the number of medical institutes and its enrollees, growing adoption of the simulation model, and an increase in focus on patient safety & minimizing medical errors.

Key players operating in the medical simulation market are CAE, Kyoto Kagaku, Laerdal Medical, Limbs and Things, Mentice, 3D Systems, Simulab Corporation, Simulaids, Surgical Science Sweden, and Gaumard Scientific Company. Product launches, Partnerships or collaboration of market players with academic & research institutes are some of the key strategies being adopted by the market players to enhance their share in the global market.

Some of the key observations regarding the medical simulation industry include:

  • In July 2019, Laerdal acquired B-Line Medical to accelerate and expand the scope of its product lines. Both the companies are leaders in the healthcare simulation industry hence merged entity is aiming to deliver high-quality training and education to doctors and patients.
  • In July 2019, 3B Scientific acquired Cardionics, Inc. to expand the product line of the company. Cardionics auscultation products complement the overall 3B Scientific simulation line.
  • In July 2019, Surgical Science Sweden AB acquired SenseGraphics AB, a Sweden-based medical simulator software developer.
  • In April 2019, Oxford Medical Simulation, a London based VR training company, announced a partnership with NHS England’s diabetes team to provide training for doctors.
  • In December 2017, Mentice acquired Medical Simulation Corporation’s endovascular business to expand its presence in the U.S. and addition of clinical training service line. Mentice is a key player in the simulation-based performance solutions industry for endovascular therapies.
  • In January 2016, SIMnext signed a partnership agreement with Limbs & Things to introduce DR Doppler Dynamic Ultrasonography Training System (DR Doppler), a training tool. As the design of DR Doppler is portable and economical, this can be utilized in hospitals to train clinicians for the use of ultrasound during diagnosis. This training will further help to reduce medical errors and thereby improve overall patient outcomes.

Market Segmentation

By Product & Service


  • Anatomical Models
    Patient Simulators
    Task Trainers
    Interventional Simulators
    Ultrasound Simulators

  • Web-based Simulation
  • Simulation Training Services

By Technology

  • Low-fidelity Simulators
  • Medium-fidelity Simulators
  • High-fidelity Simulators

By End-User

  • Academic Institutions & Research Centers
  • Hospitals & Clinics

By Geography


  • North America
    U.S.
    Canada


  • Europe
    UK
    Germany
    France
    Spain
    Rest of Europe


  • Asia-Pacific
    China
    Japan
    India
    Australia
    South Korea
    Rest of Asia-Pacific


  • Latin America
    Brazil
    Mexico
    Rest of Latin America


  • Middle East & Africa
    GCC
    South Africa
    Rest of Middle East & Africa

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Medical Simulation
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Medical Simulation Market By Product & Service
1.2.2.1. Global Medical Simulation Market Revenue and Growth Rate Comparison By Product & Service (2015-2026)
1.2.2.2. Global Medical Simulation Market Revenue Share By Product & Service in 2018
1.2.2.3. Anatomical Models
1.2.2.3.1. Patient Simulators
1.2.2.3.2. Task Trainers
1.2.2.3.3. Interventional Simulators
1.2.2.3.4. Ultrasound Simulators
1.2.2.4. Web-based Simulation
1.2.2.5. Simulation Training Services
1.2.3. Medical Simulation Market By Technology
1.2.3.1. Global Medical Simulation Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.1.1. Low-fidelity Simulators
1.2.3.1.2. Medium-fidelity Simulators
1.2.3.1.3. High-fidelity Simulators
1.2.4. Medical Simulation Market By End-User
1.2.4.1. Global Medical Simulation Market Revenue and Growth Rate Comparison By End-User (2015-2026)
1.2.4.2. Academic Institutions & Research Centers
1.2.4.3. Hospitals & Clinics
1.2.5. Medical Simulation Market By Geography
1.2.5.1. Global Medical Simulation Market Revenue and Growth Rate Comparison By Geography (2015-2026)
1.2.5.2. North America Medical Simulation Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Medical Simulation Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Medical Simulation Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Medical Simulation Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Medical Simulation Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Medical Simulation Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Medical Simulation Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Medical Simulation Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Medical Simulation Major Manufacturers in 2018

CHAPTER 4. MEDICAL SIMULATION MARKET BY PRODUCT & SERVICE
4.1. Global Medical Simulation Revenue By Product & Service
4.2. Anatomical Models
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Patient Simulators
4.2.4. Task Trainers
4.2.5. Interventional Simulators
4.2.6. Ultrasound Simulators
4.3. Web-based Simulation
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Simulation Training Services
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. MEDICAL SIMULATION MARKET BY TECHNOLOGY
5.1. Global Medical Simulation Revenue By Technology
5.2. Low-fidelity Simulators
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Medium-fidelity Simulators
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. High-fidelity Simulators
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. MEDICAL SIMULATION MARKET BY END-USER
6.1. Global Medical Simulation Revenue By End-User
6.2. Academic Institutions & Research Centers
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Hospitals & Clinics
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA MEDICAL SIMULATION MARKET BY COUNTRY
7.1. North America Medical Simulation Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Medical Simulation Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Medical Simulation Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE MEDICAL SIMULATION MARKET BY COUNTRY
8.1. Europe Medical Simulation Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Medical Simulation Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC MEDICAL SIMULATION MARKET BY COUNTRY
9.1. Asia-Pacific Medical Simulation Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Medical Simulation Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA MEDICAL SIMULATION MARKET BY COUNTRY
10.1. Latin America Medical Simulation Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Medical Simulation Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA MEDICAL SIMULATION MARKET BY COUNTRY
11.1. Middle East & AFRICA Medical Simulation Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East & AFRICA Medical Simulation Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
11.5. Rest of Middle East & AFRICA
11.5.1. Market Revenue and Forecast By Product & Service, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. CAE
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Type Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Kyoto Kagaku
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Type Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Laerdal Medical
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Type Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Limbs and Things
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Type Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Mentice
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Type Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. 3D Systems
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Type Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Simulab Corporation
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Type Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Simulaids
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Type Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Surgical Science Sweden
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Type Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Gaumard Scientific
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Type Portfolio
12.10.5. Key Developments
12.10.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/1648

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.